Inactive SARS-CoV-2 vaccine generates high antibody responses in healthcare workers with and without prior infection

[1]  M. Hassany,et al.  Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial. , 2021, JAMA.

[2]  P. Klenerman,et al.  SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) , 2021, The Lancet.

[3]  Wildo Navegantes de Araújo,et al.  Effectiveness of CoronaVac in the setting of high SARS-CoV-2 P.1 variant transmission in Brazil: A test-negative case-control study , 2021, medRxiv.

[4]  R. Karaali,et al.  [Evaluation of the Diagnostic Performance of Different Principles of SARS-CoV-2 Commercial Antibody Tests in COVID-19 Patients]. , 2021, Mikrobiyoloji Bulteni.

[5]  K. Makar,et al.  WHO International Standard for anti-SARS-CoV-2 immunoglobulin , 2021, The Lancet.

[6]  D. Aran.  Estimating real-world COVID-19 vaccine effectiveness in Israel , 2021, medRxiv.

[7]  Yingmei Feng,et al.  Single-Cell Sequencing and Immune Function Assays of Peripheral Blood Samples Demonstrate Positive Responses of an Inactivated SARS-CoV-2 Vaccine , 2021 .

[8]  D. Stuart,et al.  Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers , 2020, The New England journal of medicine.

[9]  K. Chu,et al.  Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial , 2020, The Lancet Infectious Diseases.

[10]  Christl A. Donnelly,et al.  The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries , 2020, Science.

[11]  Xiangxi Wang,et al.  Development of an inactivated vaccine candidate for SARS-CoV-2 , 2020, Science.

[12]  Reem A Mustafa,et al.  Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  Lei Liu,et al.  A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients , 2020, Microbes and Infection.

[14]  Plasma , 2019, Reactions Weekly.

[15]  Y. Leo,et al.  Profiles of Antibody Responses against Severe Acute Respiratory Syndrome Coronavirus Recombinant Proteins and Their Potential Use as Diagnostic Markers , 2004, Clinical Diagnostic Laboratory Immunology.

[16]  A. H. Wang,et al.  Early detection of antibodies against various structural proteins of the SARS-associated coronavirus in SARS patients , 2004, Journal of Biomedical Science.